Brivaracetam
From Wikipedia, the free encyclopedia
| Brivaracetam | |
|---|---|
 |
 |
| IUPAC name | (2S)-2-[(4R)-2-oxo- 4-propylpyrrolidin-1-yl] butanamide |
| Properties | |
| Molecular formula | C11H20N2O2 |
| Molar mass | 212.29 g mol-1 |
| Pharmacology | |
| Routes of administration |
Oral |
| Except where noted otherwise, data are given for materials in their standard state (at 25 °C, 100 kPa) Infobox disclaimer and references |
|
Brivaracetam is a racetam derivative with anticonvulsant properties.[1][2]
[edit] References
- ^ von Rosenstiel P (2007). "Brivaracetam (UCB 34714)". Neurotherapeutics 4 (1): 84–7. doi:. PMID 17199019.
- ^ Malawska B, Kulig K (2005). "Brivaracetam UCB". Curr Opin Investig Drugs 6 (7): 740–6. PMID 16044671.
 |
This anticonvulsant-related article is a stub. You can help Wikipedia by expanding it. |
|
|||||
